Skip to main content
Clinical Trials/NCT02577562
NCT02577562Approved For MarketingNot Applicable

Zenith® Fenestrated AAA Endovascular Graft Clinical Study

Cook Group Incorporated15 sites in 1 countryStarted: October 16, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Approved For Marketing
Locations
15

Study Overview

Brief Summary

The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.

Study Design

Study Type
Expanded Access

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Abdominal aortic and aortoiliac aneurysms with diameter greater than or equal to 5 cm

Exclusion Criteria

  • Proximal neck less than 4 mm or greater than or equal to 15 mm in length unless otherwise compromised to preclude seal
  • Renal artery stenosis greater than 50 percent

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (15)

Loading locations...

Similar Trials